Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
New non-opioid painkiller Journavx approved by FDA
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.
19h
on MSN
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
19h
on MSN
Brand-new painkiller approved by US health agency
Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 million ...
AFP
1d
Vertex Announces FDA Approval of JOURNAVXâ„¢ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Small plane crashes in Philly
Black boxes recovered
Receives $250K settlement
Boy, 5, dies in explosion
WBD hit with copyright suit
Apologizes for old tweets
Drone pilot to plead guilty
To again run for Senate?
Tour boat captain sentenced
Ends abortion travel policy
Granted legal personhood
Todd exits NBC News
Top leaders asked to resign
Opens probe into NPR, PBS
Dismisses suit against CNN
IL won’t hire Jan. 6 rioters
Cancerous tumor removed
New York doctor indicted
Recuses self from Act 10 suit
Seeking a new trial
Activists call for boycott
Gold hits all-time high
US inflation ticked higher
Walgreens suspends dividend
Confirmed interior secretary
To raise hourly pay
Olympic gold medalist dies
Judge blocks funding freeze
FDA approves painkiller
In talks to reincorporate?
TN settles suit with NCAA
Feedback